Synalloy Reports Strong Second Quarter 2022 Results
Synalloy Corporation (Nasdaq: SYNL) reported a robust second quarter of 2022, achieving year-over-year growth for the fifth consecutive quarter. Key financial metrics include a 40% increase in net sales to $116.2 million and a 283% surge in net income to $11.1 million compared to Q2 2021. Adjusted EBITDA rose 58% to $15.5 million, reflecting operational improvements and a favorable shift to higher-margin products. The company plans to rebrand as Ascent Industries Co. on August 10, 2022, aligning its strategy with long-term goals to enhance value for shareholders.
- 40% increase in net sales to $116.2 million from $83.1 million in Q2 2021.
- Net income surged 283% to $11.1 million, compared to $2.9 million in the prior year.
- Adjusted EBITDA rose 58% to $15.5 million, improving the adjusted EBITDA margin to 13.3%.
- Specialty Chemicals segment net sales nearly doubled, increasing 94% to $29.0 million.
- None.
Upcoming Rebrand to
Second Quarter 2022 Summary
(in millions, expect per share and margin) |
Q2 20221 |
Q2 2021 |
Change |
|||
|
|
|
|
|||
Gross Profit |
|
|
|
|||
Gross Profit Margin |
|
|
100bps |
|||
Net Income |
|
|
|
|||
Diluted Earnings per share |
|
|
|
|||
Adjusted EBITDA |
|
|
|
|||
Adjusted EBITDA Margin |
|
|
160bps |
Management Commentary
“After a strong start to the year, we sustained our momentum and generated a fifth consecutive quarter of year-over-year growth across the top and bottom line,” said
“As recently announced, our rebrand to
1 The second quarter of 2022 included
“For the back half of the year, we expect to continue executing on our strategic priorities: refining and progressing our commercial strategy, identifying and investing in automation and technology, further integrating our facilities to promote cross-functional work processes, and improving labor and asset mixes to maximize our working capital use. We remain steadfast in our commitment towards driving long-term, sustainable growth through our robust platform and creating value for our shareholders.”
Second Quarter 2022 Financial Results
Net sales increased
Gross profit increased
Net income increased significantly to
Adjusted EBITDA increased
Segment Results
Metals – Net sales in the second quarter of 2022 increased
Specialty Chemicals – Net sales in the second quarter of 2022 increased
Liquidity
As of
Rebrand to
As a reminder, Synalloy’s rebrand to
The Company’s corporate website, including the investor relations portion of the site, will be relocating to www.ascentco.com. Additionally, the public will be able to reach the investor relations department at ACNT@gatewayir.com.
In celebration of the Company’s rebrand, the executive leadership team will be visiting the Nasdaq MarketSite in
To view a video of the Company’s rebranded vision coming to life, please click here.
Conference Call
Date:
Time:
Live Call Registration Link: Here
Webcast Registration Link: Here
To access the call by phone, please register via the live call registration link above or here and you will be provided with dial-in instructions and details. If you have any difficulty connecting with the conference call, please contact
The conference call will also be broadcast live and available for replay via the webcast registration link above or here. The webcast will be archived for one year in the investor relations section of the Company’s website at www.synalloy.com.
About
Forward-Looking Statements
This press release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements and to review the risks. as set forth in more detail in
Non-GAAP Financial Information
Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.
Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense (including change in fair value of interest rate swap), income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, proxy contest costs and recoveries, loss on extinguishment of debt, earn-out adjustments, realized and unrealized (gains) and losses on investments in equity securities and other investments, retention costs and restructuring & severance costs from net income.
Management believes that these non-GAAP measures provide additional useful information to allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.
Condensed Consolidated Balance Sheets ($ in thousands) |
|||||
|
(Unaudited) |
|
|
||
|
|
|
|
||
Assets |
|
|
|
||
Current assets: |
|
|
|
||
Cash and cash equivalents |
$ |
245 |
|
$ |
2,021 |
Accounts receivable, net of allowance for credit losses of |
|
63,932 |
|
|
50,126 |
Inventories, net |
|
134,529 |
|
|
103,249 |
Prepaid expenses and other current assets |
|
4,883 |
|
|
3,728 |
Assets held for sale |
|
785 |
|
|
855 |
Total current assets |
|
204,374 |
|
|
159,979 |
Property, plant and equipment, net |
|
42,177 |
|
|
43,720 |
Right-of-use assets, operating leases, net |
|
29,950 |
|
|
30,811 |
|
|
12,637 |
|
|
12,637 |
Intangible assets, net |
|
12,940 |
|
|
14,382 |
Deferred charges, net |
|
253 |
|
|
302 |
Other non-current assets, net |
|
4,110 |
|
|
4,171 |
Total assets |
$ |
306,441 |
|
$ |
266,002 |
|
|
|
|
||
Liabilities and Shareholders' Equity |
|
|
|
||
Current liabilities: |
|
|
|
||
Accounts payable |
$ |
56,167 |
|
$ |
32,318 |
Accounts payable - related parties |
|
2 |
|
|
2 |
Accrued expenses and other current liabilities |
|
10,800 |
|
|
12,407 |
Current portion of note payable |
|
871 |
|
|
— |
Current portion of long-term debt |
|
2,464 |
|
|
2,464 |
Current portion of earn-out liabilities |
|
415 |
|
|
1,961 |
Current portion of operating lease liabilities |
|
1,061 |
|
|
1,104 |
Current portion of finance lease liabilities |
|
259 |
|
|
233 |
Total current liabilities |
|
72,039 |
|
|
50,489 |
Long-term debt |
|
65,849 |
|
|
67,928 |
Long-term portion of operating lease liabilities |
|
31,445 |
|
|
32,059 |
Long-term portion of finance lease liabilities |
|
1,363 |
|
|
1,414 |
Deferred income taxes |
|
1,791 |
|
|
2,433 |
Other long-term liabilities |
|
70 |
|
|
89 |
Total non-current liabilities |
|
100,518 |
|
|
103,923 |
|
|
|
|
||
Commitments and contingencies |
|
|
|
||
|
|
|
|
||
Shareholders' equity: |
|
|
|
||
Common stock, par value |
|
11,085 |
|
|
11,085 |
Capital in excess of par value |
|
46,162 |
|
|
46,058 |
Retained earnings |
|
84,397 |
|
|
63,080 |
|
|
141,644 |
|
|
120,223 |
Less: cost of common stock in treasury - 825,570 and 918,471 shares, respectively |
|
7,760 |
|
|
8,633 |
Total shareholders' equity |
|
133,884 |
|
|
111,590 |
Total liabilities and shareholders' equity |
$ |
306,441 |
|
$ |
266,002 |
Note: The condensed consolidated balance sheet at
Condensed Consolidated Statements of Income - Comparative Analysis (Unaudited) ($ in thousands, except per share data) |
||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
|||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Net sales |
|
|
|
|
|
|
|
|||||
|
Metals Segment |
$ |
87,182 |
|
$ |
68,097 |
|
$ |
175,679 |
|
$ |
123,311 |
|
Specialty Chemicals Segment |
|
29,020 |
|
|
14,990 |
|
|
56,741 |
|
|
29,554 |
|
|
$ |
116,202 |
|
$ |
83,087 |
|
$ |
232,420 |
|
$ |
152,865 |
Operating income (loss) |
|
|
|
|
|
|
||||||
|
Metals Segment |
$ |
12,934 |
|
$ |
7,504 |
|
$ |
27,426 |
|
$ |
10,081 |
|
Specialty Chemicals Segment |
|
2,627 |
|
|
(414) |
|
|
5,014 |
|
|
642 |
|
|
|
|
|
|
|
|
|
||||
Unallocated expense (income) |
|
|
|
|
|
|
|
|||||
|
Corporate |
|
3,322 |
|
|
1,360 |
|
|
6,351 |
|
|
3,127 |
|
Acquisition costs and other |
|
157 |
|
|
— |
|
|
688 |
|
|
— |
|
Proxy contest costs and recoveries |
|
— |
|
|
632 |
|
|
— |
|
|
168 |
|
Earn-out adjustments |
|
(109) |
|
|
1,044 |
|
|
(7) |
|
|
1,270 |
|
Operating income |
|
12,191 |
|
|
4,054 |
|
|
25,408 |
|
|
6,158 |
|
Interest expense |
|
407 |
|
|
353 |
|
|
810 |
|
|
739 |
|
Change in fair value of interest rate swap |
|
— |
|
|
— |
|
|
— |
|
|
(2) |
|
Loss on extinguishment of debt |
|
— |
|
|
— |
|
|
— |
|
|
223 |
|
Other, net |
|
(23) |
|
|
— |
|
|
(58) |
|
|
162 |
Income before income taxes |
|
11,807 |
|
|
3,701 |
|
|
24,656 |
|
|
5,036 |
|
|
Income tax provision |
|
750 |
|
|
815 |
|
|
3,339 |
|
|
1,056 |
Net income |
$ |
11,057 |
|
$ |
2,886 |
|
$ |
21,317 |
|
$ |
3,980 |
|
|
|
|
|
|
|
|
|
|
||||
Net income per common share |
|
|
|
|
|
|
|
|||||
|
Basic |
$ |
1.08 |
|
$ |
0.31 |
|
$ |
2.08 |
|
$ |
0.43 |
|
Diluted |
$ |
1.06 |
|
$ |
0.31 |
|
$ |
2.05 |
|
$ |
0.43 |
|
|
|
|
|
|
|
|
|
||||
Average shares outstanding |
|
|
|
|
|
|
|
|||||
|
Basic |
|
10,244 |
|
|
9,233 |
|
|
10,226 |
|
|
9,212 |
|
Diluted |
|
10,431 |
|
|
9,331 |
|
|
10,377 |
|
|
9,315 |
|
|
|
|
|
|
|
|
|
||||
Other data: |
|
|
|
|
|
|
|
|||||
|
Adjusted EBITDA1 |
$ |
15,453 |
|
$ |
9,763 |
|
$ |
32,414 |
|
$ |
14,639 |
|
|
|
|
|
|
|
|
|
1The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense (including change in fair value of interest rate swap), income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, proxy contest costs and recoveries, loss on extinguishment of debt, earn-out adjustments, realized and unrealized (gains) and losses on investments in equity securities and other investments, retention costs and restructuring & severance costs from net income. For a reconciliation of this non-GAAP measure to the most comparable GAAP equivalent, refer to the Reconciliation of Net Income (Loss) to Adjusted EBITDA.
Consolidated Statements of Cash Flows (Unaudited) ($ in thousands) |
|||||
|
Six Months Ended |
||||
|
|
2022 |
|
|
2021 |
Operating activities |
|
|
|
||
Net income |
$ |
21,317 |
|
$ |
3,980 |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||
Depreciation expense |
|
4,208 |
|
|
3,591 |
Amortization expense |
|
1,442 |
|
|
1,360 |
Amortization of debt issuance costs |
|
49 |
|
|
46 |
Asset impairments |
|
— |
|
|
233 |
Loss on extinguishment of debt |
|
— |
|
|
223 |
Deferred income taxes |
|
(642) |
|
|
(76) |
Earn-out adjustments |
|
(7) |
|
|
1,270 |
Payments of earn-out liabilities in excess of acquisition date fair value
|
|
(372) |
|
|
— |
Provision for (reduction of) losses on accounts receivable |
|
532 |
|
|
(362) |
Provision for losses on inventories |
|
1,234 |
|
|
368 |
Gain on disposal of property, plant and equipment |
|
(5) |
|
|
(81) |
Non-cash lease expense |
|
214 |
|
|
249 |
Change in fair value of interest rate swap |
|
— |
|
|
(2) |
Issuance of treasury stock for director fees |
|
364 |
|
|
— |
Stock-based compensation expense |
|
452 |
|
|
456 |
Changes in operating assets and liabilities: |
|
|
|
||
Accounts receivable |
|
(14,339) |
|
|
(12,536) |
Inventories |
|
(32,442) |
|
|
(5,482) |
Other assets and liabilities |
|
(1,022) |
|
|
(570) |
Accounts payable |
|
23,591 |
|
|
5,575 |
Accounts payable - related parties |
|
— |
|
|
632 |
Accrued expenses |
|
(1,795) |
|
|
1,370 |
Accrued income taxes |
|
110 |
|
|
4,751 |
Net cash provided by operating activities |
|
2,889 |
|
|
4,995 |
Investing activities |
|
|
|
||
Purchases of property, plant and equipment |
|
(2,330) |
|
|
(563) |
Proceeds from disposal of property, plant and equipment |
|
5 |
|
|
138 |
Net cash used in investing activities |
|
(2,325) |
|
|
(425) |
Financing activities |
|
|
|
||
Borrowings from long-term debt |
|
237,938 |
|
|
38,398 |
Proceeds from note payable |
|
967 |
|
|
— |
Proceeds from the exercise of stock options |
|
161 |
|
|
— |
Payments on long-term debt |
|
(240,017) |
|
|
(40,269) |
Payments on note payable |
|
(96) |
|
|
— |
Principal payments on finance lease obligations |
|
(126) |
|
|
(19) |
Payments on earn-out liabilities |
|
(1,167) |
|
|
(1,944) |
Payments for termination of interest rate swap |
|
— |
|
|
(46) |
Payments for deferred financing costs |
|
— |
|
|
(165) |
Net cash used in financing activities |
|
(2,340) |
|
|
(4,045) |
(Decrease) increase in cash and cash equivalents |
|
(1,776) |
|
|
525 |
Cash and cash equivalents, beginning of period |
|
2,021 |
|
|
236 |
Cash and cash equivalents, end of period |
$ |
245 |
|
$ |
761 |
|
|
|
|
||
Supplemental Disclosure of Cash Flow Information |
|
|
|
||
Cash paid for: |
|
|
|
||
Interest |
$ |
699 |
|
$ |
620 |
Income taxes |
$ |
3,874 |
|
$ |
24 |
|
|
|
|
||
Noncash Investing Activities: |
|
|
|
||
Capital expenditures, not yet paid |
$ |
336 |
|
$ |
— |
Non-GAAP Financial Measures Reconciliation Reconciliation of Net Income to Adjusted EBITDA (Unaudited) ($ in thousands) |
||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
|||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Consolidated |
|
|
|
|
|
|
|
|||||
Net income |
$ |
11,057 |
|
$ |
2,886 |
|
$ |
21,317 |
|
$ |
3,980 |
|
Adjustments: |
|
|
|
|
|
|
|
|||||
|
Interest expense |
|
407 |
|
|
353 |
|
|
810 |
|
|
739 |
|
Change in fair value of interest rate swap |
|
— |
|
|
— |
|
|
— |
|
|
(2) |
|
Income taxes |
|
750 |
|
|
815 |
|
|
3,339 |
|
|
1,056 |
|
Depreciation |
|
2,092 |
|
|
1,774 |
|
|
4,208 |
|
|
3,591 |
|
Amortization |
|
721 |
|
|
680 |
|
|
1,442 |
|
|
1,360 |
EBITDA |
|
15,027 |
|
|
6,508 |
|
|
31,116 |
|
|
10,724 |
|
|
Acquisition costs and other |
|
157 |
|
|
— |
|
|
688 |
|
|
— |
|
Proxy contest costs and recoveries1 |
|
— |
|
|
632 |
|
|
— |
|
|
168 |
|
Loss on extinguishment of debt |
|
— |
|
|
— |
|
|
— |
|
|
223 |
|
Earn-out adjustments |
|
(109) |
|
|
1,044 |
|
|
(7) |
|
|
1,270 |
|
Loss on investment in equity securities and other investments |
|
— |
|
|
— |
|
|
— |
|
|
363 |
|
Asset impairments |
|
— |
|
|
233 |
|
|
— |
|
|
233 |
|
Gain on lease modification |
|
(2) |
|
|
— |
|
|
(2) |
|
|
— |
|
Stock-based compensation |
|
263 |
|
|
269 |
|
|
395 |
|
|
456 |
|
Non-cash lease expense |
|
107 |
|
|
124 |
|
|
214 |
|
|
249 |
|
Retention expense |
|
— |
|
|
476 |
|
|
— |
|
|
476 |
|
Restructuring and severance costs |
|
10 |
|
|
477 |
|
|
10 |
|
|
477 |
Adjusted EBITDA |
$ |
15,453 |
|
$ |
9,763 |
|
$ |
32,414 |
|
$ |
14,639 |
|
|
% sales |
|
13.3 % |
|
|
11.7 % |
|
|
13.9 % |
|
|
9.6 % |
1Proxy contest costs and recoveries for the three months ended
Non-GAAP Financial Measures Reconciliation Reconciliation of Net Income to Adjusted EBITDA (Unaudited) ($ in thousands) |
||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
|||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Metals Segment |
|
|
|
|
|
|
|
|||||
Net income |
$ |
13,074 |
|
$ |
6,463 |
|
$ |
27,498 |
|
$ |
9,002 |
|
Adjustments: |
|
|
|
|
|
|
|
|||||
|
Depreciation expense |
|
1,163 |
|
|
1,350 |
|
|
2,376 |
|
|
2,742 |
|
Amortization expense |
|
625 |
|
|
680 |
|
|
1,250 |
|
|
1,360 |
EBITDA |
|
14,862 |
|
|
8,493 |
|
|
31,124 |
|
|
13,104 |
|
|
Earn-out adjustments |
|
(109) |
|
|
1,044 |
|
|
(7) |
|
|
1,270 |
|
Stock-based compensation |
|
(11) |
|
|
46 |
|
|
24 |
|
|
83 |
|
Non-cash lease expense |
|
(1) |
|
|
— |
|
|
(1) |
|
|
— |
|
Retention expense |
|
— |
|
|
476 |
|
|
— |
|
|
476 |
|
Restructuring and severance costs |
|
— |
|
|
50 |
|
|
— |
|
|
50 |
Metals Segment Adjusted EBITDA |
$ |
14,741 |
|
$ |
10,109 |
|
$ |
31,140 |
|
$ |
14,983 |
|
|
% segment sales |
|
16.9 % |
|
|
14.8 % |
|
|
17.7 % |
|
|
12.2 % |
|
|
|
|
|
|
|
|
|
||||
Specialty Chemicals Segment |
|
|
|
|
|
|
|
|||||
Net income (loss) |
$ |
2,617 |
|
$ |
(414) |
|
$ |
4,995 |
|
$ |
641 |
|
Adjustments: |
|
|
|
|
|
|
|
|||||
|
Interest expense |
|
9 |
|
|
— |
|
|
18 |
|
|
— |
|
Depreciation expense |
|
915 |
|
|
390 |
|
|
1,800 |
|
|
776 |
|
Amortization expense |
|
96 |
|
|
— |
|
|
192 |
|
|
— |
EBITDA |
|
3,637 |
|
|
(24) |
|
|
7,005 |
|
|
1,417 |
|
|
Acquisition costs and other |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Asset impairments |
|
— |
|
|
233 |
|
|
— |
|
|
233 |
|
Stock-based compensation |
|
11 |
|
|
136 |
|
|
18 |
|
|
167 |
|
Restructuring and severance costs |
|
— |
|
|
427 |
|
|
— |
|
|
427 |
Specialty Chemicals Segment Adjusted EBITDA |
$ |
3,648 |
|
$ |
772 |
|
$ |
7,023 |
|
$ |
2,244 |
|
|
% segment sales |
|
12.6 % |
|
|
5.2 % |
|
|
12.4 % |
|
|
7.6 % |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005817/en/
Company
Chief Financial Officer
1-804-822-3260
Investor Relations
1-949-574-3860
SYNL@gatewayir.com
Source:
FAQ
What were Synalloy Corporation's financial results for Q2 2022?
When is Synalloy Corporation rebranding to Ascent Industries Co.?
What is the stock ticker symbol for Synalloy Corporation after the rebrand?
How did Synalloy's net income change from Q2 2021 to Q2 2022?